This content is machine translated Biologics for IBD Therapy break – what speaks for and against it In the treatment of chronic inflammatory bowel disease (IBD), effective control of inflammation is fundamental, and an early switch to novel therapies to avoid long-term complications is also emphasized in…
View Post 6 min This content is machine translated IBD in children and adolescents Calprotectin concentration and PUCAI score are indicative The prevalence of chronic inflammatory bowel diseases (IBD) such as Crohn’s disease (MC) and ulcerative colitis (UC) has also been increasing in recent years.in the age groups of children and…
View Post 13 min This content is machine translated Chronic inflammatory bowel disease Treatment options for vulnerable patient populations Vulnerable patient populations with inflammatory bowel disease (IBD) require individualized and advanced treatment options. For example, the proportion of childless individuals with IBD is increased, often due to inadequate information… CME-Test
View Post 10 min This content is machine translated Chronic inflammatory bowel disease (CED) Modern “State-of-the-Art” Pharmacotherapy – an Update Modern approaches to the treatment of inflammatory bowel disease (IBD) are based on the motto “treat-to-target”, whereby in addition to symptom relief and induction of disease remission, the aim nowadays… CME-Test
View Post 4 min This content is machine translated Chronic inflammatory bowel disease The therapy goal is the control of the disease Inflammatory bowel disease (IBD) refers to relapsing or continuous inflammatory diseases of the intestine. Crohn’s disease and ulcerative colitis belong to this group of forms. “Don’t be afraid of guidelines,”…